CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
The DxC 500 received FDA clearance in July 2023. It is for in vitro diagnostic use only and is available in North America and the Middle East. Worldwide commercial availability is planned for March.
Pages: 1 2
The DxC 500 received FDA clearance in July 2023. It is for in vitro diagnostic use only and is available in North America and the Middle East. Worldwide commercial availability is planned for March.
Tagged with: Beckman Coulter Diagnostics